Metronidazole

Generic Name
Metronidazole
Brand Names
Flagyl, Flagystatin, Likmez, Metrocream, Metrogel, Metrolotion, Nidagel, Noritate, Nuvessa, Pylera, Rosadan, Vandazole
Drug Type
Small Molecule
Chemical Formula
C6H9N3O3
CAS Number
443-48-1
Unique Ingredient Identifier
140QMO216E
Background

Metronidazole is a commonly used antibiotic, belonging to the nitroimidazole class of antibiotics. It is frequently used to treat gastrointestinal infections as well as trichomoniasis and giardiasis, and amebiasis which are parasitic infections. Metronidazole has been used as an antibiotic for several decades, with added antiparasitic properties that set it ...

Indication

Metronidazole is indicated for the treatment of confirmed trichomoniasis caused by Trichomonas vaginalis (except for in the first trimester of pregnancy) and the patient's sexual partners, bacterial vaginosis, certain types of amebiasis, and various anaerobic infections. The above anaerobic infections may occur on the skin and skin structures, the abdomen, t...

Associated Conditions
Abscess Brain, Abscess, Intra-Abdominal, Anaerobic Bacterial Infection, Bacterial Endocarditis, Bacterial Peritonitis, Bacterial Septicemia, Bacterial Vaginosis (BV), Balantidiasis, Bone and Joint Infections, Central Nervous System Bacterial Infections, Empyema, Endometritis, Endomyometritis, Facial Rosacea, Giardiasis, Gynecological Infection, Helicobacter Pylori Infection, Inflammatory Papule, Inflammatory pustules, Liver Abscess, Amebic, Lower respiratory tract infection bacterial, Lung Abscess, Meningitis, Mixed Vaginal Infections, Mixed Vaginal Infections caused by Trichomonas Vaginalis, candida albicans, Periodontitis, Pneumonia, Postoperative Infections, Pouchitis, Skin and skin structure infections, Tetanus, Trichomonas Vaginitis, Tubo-ovarian abscess, Vaginal Candidiasis, Vaginitis Trichomonal, Vulvovaginitis, Acute Intestinal amebiasis, Asymptomatic Trichomoniasis, Entamoeba histolytica, Hepatic abscess, Intra-abdominal bacterial infections, Post-surgical vaginal cuff infection, Refractory Sinusitis, Symptomatic Trichomoniasis
Associated Therapies
-

Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication

First Posted Date
2015-11-04
Last Posted Date
2017-02-28
Lead Sponsor
Chang Gung Memorial Hospital
Target Recruit Count
164
Registration Number
NCT02596620

Once Daily Metronidazole for Perforated Appendicitis

Phase 4
Withdrawn
Conditions
Interventions
First Posted Date
2015-09-25
Last Posted Date
2017-07-21
Lead Sponsor
Ahmed Nasr
Registration Number
NCT02561117

Effect of Bacterial Vaginosis on HIV Susceptibility and Female Genital Immunology

Phase 1
Completed
Conditions
Interventions
First Posted Date
2015-08-19
Last Posted Date
2016-02-10
Lead Sponsor
University of Toronto
Target Recruit Count
50
Registration Number
NCT02527941
Locations
🇰🇪

Kenya AIDS Vaccine Initiative Clinic, Nairobi, Kenya

Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).

First Posted Date
2015-06-19
Last Posted Date
2018-08-09
Lead Sponsor
Pfizer
Target Recruit Count
83
Registration Number
NCT02475733
Locations
🇺🇸

CHOC Children's, Orange, California, United States

🇨🇿

Oblastni Nemocnice Kolin, a.s., Nemocnice Stredoceskeho Kraje, Detske oddeleni, Kolin III, Czechia

🇺🇸

Rady Children's Hospital San Diego, San Diego, California, United States

and more 32 locations

Study of Levofloxacin-based Concomitant Therapy for H. Pylori Eradication in Diabetic Patients

First Posted Date
2015-06-09
Last Posted Date
2016-09-02
Lead Sponsor
Chung-Tai Wu
Target Recruit Count
114
Registration Number
NCT02466919

Intestinal Lavage for the Treatment of Severe C. Difficile Infections

First Posted Date
2015-06-09
Last Posted Date
2018-08-13
Lead Sponsor
Lawson Health Research Institute
Target Recruit Count
20
Registration Number
NCT02466698
Locations
🇨🇦

London Health Sciences Centre, London, Ontario, Canada

Antibiotic Treatment Trial for Small Intestinal Bacterial Overgrowth

First Posted Date
2015-06-01
Last Posted Date
2015-06-01
Lead Sponsor
San Antonio Military Medical Center
Target Recruit Count
180
Registration Number
NCT02458781

The Role of the Microbiota in the Systemic Immune Response

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2015-01-16
Last Posted Date
2015-01-16
Lead Sponsor
W.J. Wiersinga, MD, PhD
Target Recruit Count
12
Registration Number
NCT02340182
Locations
🇳🇱

Academisch Medisch Centrum, Amsterdam, Noord-Holland, Netherlands

The Effects of Nitazoxanide in Hepatic Encephalopathy

First Posted Date
2015-01-08
Last Posted Date
2015-01-08
Lead Sponsor
Ain Shams University
Target Recruit Count
36
Registration Number
NCT02334163
Locations
🇪🇬

Faculty of medicine, Ain Shams University, Cairo, Egypt

© Copyright 2024. All Rights Reserved by MedPath